News

Pfizer China and BMP Sunstone have entered into a strategic partnership to import, distribute and promote Depo-Provera (Medroxy-progesterone Acetate), a Pfizer product used to treat endometriosis, in China.

ARmark Authentication Technologies (ARmark) and Colorcon have entered into an alliance in the development and introduction of ®mark On-Dose ID, an authentication technology that incorporates microscopic covert micro-tags

Life Technologies, has signed a definitive agreement to acquire BioTrove, for an undisclosed amount. This acquisition builds on a collaboration that Applied Biosystems entered into with BioTrove in

Teva Pharmaceutical (Teva) is seeking to amend its existing complaint against Momenta Pharmaceuticals/Sandoz to include patent infringement of three additional patents related to the characterisation of Copaxone (glatiramer

Cerimon Pharmaceuticals has acquired exclusive rights to develop and commercialise diclofenac sodium patch in Europe, including most countries in the the EU, Turkey, Switzerland, Norway, the Balkan countries

Kineta has been awarded a $6.8m subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The grant is

Trin Pharma (Trin) has reported that BfArM, the German Regulatory Authority, has approved the start of a Phase I clinical trial of TRIN 2755 in solid tumors. The

Mylan has reported that its privately held Indian subsidiary, Matrix Laboratories, has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Lansoprazole delayed-release

Spectrum Pharmaceuticals (Spectrum) and Nippon Kayaku have entered into an exclusive collaboration for the development and commercialisation of Apaziquone in Asia. Apaziquone is an antineoplastic agent currently being